Insulet financial statements
인슐릿NASDAQ:PODD · Nasdaq · Healthcare$135.62+2.98%
2026-10-05 close · prelimInsulet's published financial data is dated 2026-10-04. 2024 revenue was $2.07B. 2024 operating profit was $309M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy